MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
MGNXMacroGenics(MGNX) ZACKS·2024-08-07 06:32

MacroGenics (MGNX) came out with a quarterly loss of 0.89pershareversustheZacksConsensusEstimateofalossof0.89 per share versus the Zacks Consensus Estimate of a loss of 0.47. This compares to loss of 0.36pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−89.360.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -89.36%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 0.67 per share when it actually produced a loss of $0.84, delivering a surprise of -25.37%.Over the last four quarters, the comp ...